Adjuvant Treatment of Digestive Tract Tumors
NCT05742620
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Adjuvant Treatment
Interventions
DRUG:
anlotinib+CAPEOX/SOX
Sponsor
Xijing Hospital